Literature DB >> 20186081

Central giant cell granuloma of the jaws.

Gianluca Nicolai1, Bruno Lorè, Giulio Mariani, Patrizio Bollero, Leonardo De Marinis, Leonardo Calabrese.   

Abstract

Central giant cell granuloma was classified by the World Health Organization in 2005 as a rarely aggressive idiopathic benign intraosseous lesion that occurs almost exclusively in the jaws. It occurs most frequently in young women (aged <30 y). This osteolytic lesion histologically consists of proliferation of fibrous tissue, hemorrhagic focuses, hemosiderin deposits, osteoclast-like giant cells, and reactive bone formation. Differential diagnosis has to be made with other osteolytic neoformations of the jaws, both unicystic and multicystic (odontogenic tumors, fibrous dysplasia, cysts, etc). From 2002 to 2008, we surgically treated 8 cases of giant cell granuloma. Our article focuses on a 59-year-old woman who came to our department with a swelling on the right side of the face. Computed tomography examination showed an osteolytic and expansive neoformation spreading up from the lateral wall of the nose to the anterior wall of maxillary sinus and above up to the inferior margin of the eye socket. Besides, it was contiguous to the canine root apex, the first and second bicuspids. Intraoral incisional biopsy confirmed the histologic picture of central giant cell granuloma. After a few days, she underwent surgical excision of the neoformation, preserving the lateral wall of the nose, the anterior wall of maxillary sinus, the eye socket, and the dental elements, respectively. Results of the histopathologic examination confirmed the previous biopsy. A follow-up at 30 months excluded any relapse.

Entities:  

Mesh:

Year:  2010        PMID: 20186081     DOI: 10.1097/SCS.0b013e3181cfa5d5

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  5 in total

1.  Carcinoma of the lip five years after bone marrow transplantation.

Authors:  M Ardore; M Berrone; G Marchitto; S Gandolfo; M Pentenero
Journal:  Ann Stomatol (Roma)       Date:  2015-12-01

2.  IL-4 induces the formation of multinucleated giant cells and expression of β5 integrin in central giant cell lesion.

Authors:  A Aghbali; S Rafieyan; L Mohamed-Khosroshahi; B Baradaran; D Shanehbandi; M Kouhsoltani
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-01-01

3.  Treatment of central giant cell lesions using bisphosphonates with intralesional corticosteroid injections.

Authors:  Newton Guerreiro Júnior da Silva; Aline Semblano Dias Carreira; Erick Nelo Pedreira; Fabrício Mesquita Tuji; Karem López Ortega; João de Jesus Viana Pinheiro
Journal:  Head Face Med       Date:  2012-08-22       Impact factor: 2.151

4.  Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws: a meta-analytic study.

Authors:  Rafael-Lima-Verde Osterne; Phelype-Maia Araújo; Abrahao-Cavalcante-Gomes de Souza-Carvalho; Roberta-Barroso Cavalcante; Eduardo Sant'Ana; Renato-Luiz-Maia Nongueira
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01

5.  Peripheral and Central Giant Cell Lesions in Children: Institutional Experience at Subharti Dental College and Hospital.

Authors:  Preetika Chandna; Nikhil Srivastava; Vishal Bansal; Vijay Wadhwan; Prajesh Dubey
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.